Growth stocks are still on the menu for 2026. The first few months of 2025 were a roller-coaster ride that threatened to ...

Insulet could be joining the competition to develop 'artificial pancreas' devices following the release of positive feasibility data for its solution. The Massachusetts-based company's 'hybrid ...

We independently review everything we recommend. We may make money from the links on our site. Learn more› By Geoffrey Morrison Life moves pretty quickly. If you don’t have a dash cam to record an ...

To pass muster, these units had to survive the insanity of the Hershey Bears' parking lot (ever compete for a spot with an AHL hockey fan?), a downpour on the Garden State Parkway, and D.C. rush hour.

Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes complete with a wearable continuous glucose monitor (CGM) and insulin pump.

Artur is a copywriter and SEO specialist, as well as a small business owner. In his free time, he loves to play computer games and is glad that he was able to connect his professional career with his ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

The Insulet Omnipod 5 pump and Dexcom G7 15 Day CGM. [Images courtesy of the companies] Insulet (Nasdaq:PODD) today announced immediate compatibility between its Omnipod 5 system and the Dexcom ...

The changes to Insulet’s Omnipod algorithm are intended to give users greater control over their insulin management. Image credit: Butusova Elena via Shutterstock.com. Insulet has secured US Food and ...

Insulet laid out plans for new diabetes devices at an investor event last week, including a fully automated insulin delivery system for people with Type 2 diabetes. The company is working on updates ...